Assessment of the efficacy of a 5-weeks randomized, controlled half-face treatment with topical 2.55 % PAP compared to its placebo in healthy volunteers with oily skin

OREAL RESEARCH0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Healthy male volunteers, aged 18 - 40 years,
•- Skin phototype II-V (Fitzpatrick classification),
•- Presenting an oily skin appearance on the face (sebum rate >150 mg/cm2 on the forehead right and left),
•- Acne prone subjects showing the presence of facial acne (grade 2-7 in the Leeds acne grade), presenting at least 15 inflammatory lesions and at least 25 non-inflammatory lesions on the face,
•- Able to give written informed consent and to comply with the requirements of the study.

•-Females subjects,
•- Any significant skin pathology in the test areas, like rosacea, severe acne,or eczema. (Subjects with mild to moderate acne will be acceptable provide the condition does not interfere with the objectives of the study),
•- Known hypersensitivity to any of the study drugs or constituents,
•- Any topical or systemic treatment that could interfere with the study treatments/assessments (topical benzoyl peroxide and other antiacne or antiseborreic products, antibiotics, corticosteroids, retinoids, antiinflammatory
•drugs?) within the last 4 weeks prior to participation in the study, and during the study,
•- Any surgical treatment on the test areas (laser peel, dermabrasion, etc.),
•- Subject reported or planning to sun-bath or to overexpose to UV-light (mountains sports, phototherapy, tanning salon use, etc.) for aesthetic or
•therapeutic reason the month before the study start or during the study,
•- Any significant medical condition that would interfere in the participation in the trial,
•- Participation in a clinical trial up to 1 month prior to inclusion.

发起方

OREAL RESEARCH